BRIEF published on 04/02/2025 at 18:10, 1 year 1 month ago EXACOMPTA CLAIREFONTAINE publie ses résultats financiers 2024 Baisse Des Revenus Résultats Financiers 2024 Conditions Du Marché Perspectives 2025 Performance Du Segment
BRIEF published on 04/02/2025 at 18:10, 1 year 1 month ago EXACOMPTA CLAIREFONTAINE Reports 2024 Financial Results Market Conditions Revenue Decline Segment Performance Financial Results 2024 2025 Outlook
REGULATED PRESS RELEASE published on 04/02/2025 at 18:05, 1 year 1 month ago Financial statements - 31 december 2024 EXACOMPTA CLAIREFONTAINE Board of Directors approved 2024 financial statements. Revenue: €831,274,000. Outlook cautious due to weak Q1 2025 demand Financial Statements Revenue Outlook 2024 Exacompta Clairefontaine
BRIEF published on 03/27/2025 at 18:05, 1 year 1 month ago EXACOMPTA CLAIREFONTAINE: 2024 annual results and 2025 outlook Stationery Market 2024 Results Outlook 2025 Dividend Share Paper Production
BRIEF published on 03/27/2025 at 18:05, 1 year 1 month ago EXACOMPTA CLAIREFONTAINE : Résultats annuels 2024 et perspectives 2025 Résultats 2024 Marché De La Papeterie Perspectives 2025 Production De Papier Dividende Action
REGULATED PRESS RELEASE published on 03/27/2025 at 18:00, 1 year 1 month ago Arrêté des comptes au 31 décembre 2024 et perspectives 2025 Réunion du conseil d'administration d'EXACOMPTA CLAIREFONTAINE le 27 mars 2025 à Paris pour examen des comptes 2024 et perspectives 2025 Conseil D'administration Résultats 2024 Exacompta Clairefontaine Réunion Perspectives 2025
BRIEF published on 03/03/2025 at 18:05, 1 year 2 months ago Voting Rights and Shares 2024: Exacompta Clairefontaine Report Share Capital Voting Rights Actions Financial Market Exacompta Clairefontaine
BRIEF published on 03/03/2025 at 18:05, 1 year 2 months ago Droits de Vote et Actions 2024 : Bilan d'Exacompta Clairefontaine Marché Financier Droits De Vote Capital Social Actions Exacompta Clairefontaine
REGULATED PRESS RELEASE published on 03/03/2025 at 18:00, 1 year 2 months ago Droits de vote et actions 2024 EXACOMPTA CLAIREFONTAINE déclare le nombre total de droits de vote et d’actions composant son capital pour l'année 2024 Capital Droits De Vote Actions 2024 Exacompta Clairefontaine
Published on 05/23/2026 at 03:15, 14 hours 59 minutes ago UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 15 hours 14 minutes ago Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 15 hours 49 minutes ago Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 15 hours 49 minutes ago Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 17 hours 14 minutes ago LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
Published on 05/23/2026 at 16:30, 1 hour 43 minutes ago HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 2 hours 17 minutes ago EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 20 hours 9 minutes ago Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 20 hours 9 minutes ago Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 22 hours 23 minutes ago Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 19:35, 22 hours 39 minutes ago PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day ago Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day ago Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 5 hours ago Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 5 hours ago Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
